An international team led by University of California San Diego researchers has employed a novel computational approach to design and create a new compound that in laboratory studies has reduced deficits and neurodegenerative symptoms that underlie Parkinson’s disease.
Scientists will convene Oct. 7 at Scripps Institution of Oceanography at UC San Diego to consider the future of one of the world’s longest continuous records of ocean conditions. Managers of the program, which observed the centennial of the first temperature measurement at Scripps Pier in August, will take up the question of how – and if – the program should continue into a second century as it is now and how it can be funded in the future.
Four biologists, a nanoengineer and a biophysicist at UC San Diego today received a total of more than $5 million in grants from the National Institutes of Health to pursue innovative and transformative research projects.
Physician-scientists with Moores Cancer Center at UC San Diego Health have been leading the way in pancreatic cancer care by investigating new therapies as well as offering innovative clinical trials and the latest treatments with a personalized medicine approach. This expertise led to the selection of Moores Cancer Center as one of 12 clinical trial sites for the Pancreatic Cancer Action Network’s newly created Precision Promise, the first large-scale precision medicine trial network designed to transform outcomes for patients with pancreatic cancer.
A swarm of nearly 200 small earthquakes that shook Southern California residents in the Salton Sea area last week raised concerns they might trigger a larger earthquake on the southern San Andreas Fault. At the same time, scientists from Scripps Institution of Oceanography at the University of California San Diego and the Nevada Seismological Laboratory at the University of Nevada, Reno published their recent discovery of a potentially significant fault that lies along the eastern edge of the Salton Sea.
Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
